Literature DB >> 23600610

Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.

Alexander H van Asbeck1, Andrea Beyerle, Hesta McNeill, Petra H M Bovee-Geurts, Staffan Lindberg, Wouter P R Verdurmen, Mattias Hällbrink, Ulo Langel, Olaf Heidenreich, Roland Brock.   

Abstract

Cell-penetrating peptides (CPPs) are versatile tools for the intracellular delivery of various biomolecules, including siRNA. Recently, CPPs were introduced that showed greatly enhanced delivery efficiency. However, the molecular basis of this increased activity is poorly understood. Here, we performed a detailed analysis of the molecular and physicochemical properties of seven different siRNA-CPP nanoparticles. In addition, we determined which complexes are internalized most efficiently into the leukemia cell-line SKNO-1, and subsequently inhibited the expression of a luciferase reporter gene. We demonstrated effective complexation of siRNA for all tested CPPs, and optimal encapsulation of the siRNA was achieved at very similar molar ratios independent of peptide charge. However, CPPs with an extreme high or low overall charge proved to be exceptions, suggesting an optimal range of charge for CPP-siRNA nanoparticle formation based on opposite charge. The most active CPP (PepFect6) displayed high serum resistance but also high sensitivity to decomplexation by polyanionic macromolecules, indicating the necessity for partial decomplexation for efficient uptake. Surprisingly, CPP-siRNA complexes acquired a negative ζ-potential in the presence of serum. These novel insights shed light on the observation that cell association is necessary but not sufficient for activity and motivate new research into the nature of the nanoparticle-cell interaction. Overall, our results provide a comprehensive molecular basis for the further development of peptide-based oligonucleotide transfection agents.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600610     DOI: 10.1021/nn305754c

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  33 in total

1.  Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.

Authors:  Kirk K Hou; Hua Pan; Lee Ratner; Paul H Schlesinger; Samuel A Wickline
Journal:  ACS Nano       Date:  2013-09-26       Impact factor: 15.881

2.  Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice.

Authors:  Susumu Ishiguro; Nabil A Alhakamy; Deepthi Uppalapati; Jennifer Delzeit; Cory J Berkland; Masaaki Tamura
Journal:  J Pharm Sci       Date:  2016-10-18       Impact factor: 3.534

3.  Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.

Authors:  Skye Zeller; Chang Seon Choi; Pradeep D Uchil; Hong-Seok Ban; Alyssa Siefert; Tarek M Fahmy; Walther Mothes; Sang-Kyung Lee; Priti Kumar
Journal:  Chem Biol       Date:  2014-12-24

4.  Efficient transdermal delivery of functional protein cargoes by a hydrophobic peptide MTD 1067.

Authors:  Hee Je Shin; Sun Uk Bak; Ha Na La; Jin Sun Kang; Hwa Hyun Lee; Hyo Jung Eom; Byung Kyu Lee; Hyun Ah Kang
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

5.  Reductively Responsive Hydrogel Nanoparticles with Uniform Size, Shape, and Tunable Composition for Systemic siRNA Delivery in Vivo.

Authors:  Da Ma; Shaomin Tian; Jeremy Baryza; J Christopher Luft; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2015-09-04       Impact factor: 4.939

6.  Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential.

Authors:  Yu Zhang; Melanie Köllmer; Jason S Buhrman; Mary Y Tang; Richard A Gemeinhart
Journal:  Peptides       Date:  2014-06-23       Impact factor: 3.750

Review 7.  Progress and perspective of inorganic nanoparticle-based siRNA delivery systems.

Authors:  Ying Jiang; Shuaidong Huo; Joseph Hardie; Xing-Jie Liang; Vincent M Rotello
Journal:  Expert Opin Drug Deliv       Date:  2016-01-14       Impact factor: 6.648

8.  Development of streptavidin-based nanocomplex for siRNA delivery.

Authors:  Ravi S Shukla; Wanyi Tai; Rubi Mahato; Wei Jin; Kun Cheng
Journal:  Mol Pharm       Date:  2013-10-25       Impact factor: 4.939

Review 9.  Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment.

Authors:  Deidra M Ward; Aaliyah B Shodeinde; Nicholas A Peppas
Journal:  Adv Healthc Mater       Date:  2021-05-11       Impact factor: 11.092

10.  High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.

Authors:  B Yang; X Ming; C Cao; B Laing; A Yuan; M A Porter; E A Hull-Ryde; J Maddry; M Suto; W P Janzen; R L Juliano
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.